4D pharma plc (LON: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announced that David Norwood has purchased ordinary shares in the Company as listed below. Following this transaction, Mr Norwood has a resulting interest in the ordinary shares of the Company as listed below.
Name |
|
Shares in 4D pharma plc before purchase |
% of total shares in issue |
Shares in 4D pharma plc after purchase |
% of total shares in issue |
|
|
|
|
|
|
David Norwood (Chairman) |
|
7,050,000 |
10.76% |
7,070,000 |
10.79% |